Similar articles

• Granulocyte transfusion therapy.

  Higby DJ, Henderson ES. Higby DJ, et al. Annu Rev Med. 1975;26:289-316. doi: 10.1146/annurev.me.26.020175.001445. Annu Rev Med. 1975. PMID: 1096766 Review. No abstract available.
• Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections.

  Sachs UJ, Reiter A, Walter T, Bein G, Woessmann W. Sachs UJ, et al. Transfusion. 2006 Nov;46(11):1909-14. doi: 10.1111/j.1537-2995.2006.00996.x. Transfusion. 2006. PMID: 17076845 Clinical Trial.
• Clinical efficacy and prediction of response to granulocyte transfusion therapy for patients with neutropenia-related infections.

  Lee JJ, Song HC, Chung IJ, Bom HS, Cho D, Kim HJ. Lee JJ, et al. Haematologica. 2004 May;89(5):632-3. Haematologica. 2004. PMID: 15136239
• Current status of granulocyte transfusion therapy.

  Schiffer CA, Aisner J, Wiernik PH. Schiffer CA, et al. Prog Clin Biol Res. 1977;13:281-92. Prog Clin Biol Res. 1977. PMID: 400759 Review. No abstract available.
• Multiple granulocyte transfusions facilitating successful unrelated bone marrow transplantation in a patient with very severe aplastic anemia complicated by suspected fungal infection.

  Clarke K, Szer J, Shelton M, Coghlan D, Grigg A. Clarke K, et al. Bone Marrow Transplant. 1995 Nov;16(5):723-6. Bone Marrow Transplant. 1995. PMID: 8547874